Events

VCU Health Sciences Events

Tuesday, April 24, 2018

Fear 2 Freedom

6:00pm
Larrick Student Center

Join us for VCU's 7th annual Fear 2 Freedom event to assemble care kits for surivors of sexual and intimate partner violence. The Wellness Resource Center is partnering with the YWCA of Richmond, VCU Health's Project Empower, VCU Police Department, VCU Equity and Access Services: Title IX, VCU SGA, and Students Advocating Violence Education and Support (SAVES) to put on this event in honor of Sexual Assault Awareness Month (SAAM). The event will be held at Larrick Student Center's Court End Ballrooms from 6:00-7:30pm. Free dinner provided! Volunteer at bit.ly/F2FVCU

Friday, April 27, 2018

26th Annual WISDM Leadership Conference: Models of Leadership - - Where Do You Fit?

Noon
Larrick Student Center

VCU community is invited including faculty, students, housestaff, post-docs, administrators, community practitioners and leaders to attend this half-day conference on the MCV Campus.  To register for the conference go to: https://vcu.cloud-cme.com/aph.aspx?EID=9015&P=5#

Keynote Address:  "Redefining the Metrics of Success" by Sheryl Garland, M.H.A., Vice President of Health Policy and Community Relations, VCU Health System (VCUHS), and Director of the VCU Office of Health Innovation, Virginia Commonwealth University (VCU).

Breakout sessions and lunch discussion:

  • Have you Lost Your Mind Yet? Creating a More Mindful Leadership Presence
  • Community-Engaged Leadership
  • Burnout in Health Care: Old Problem, New Solutions
  • Conflict Management: Promoting Civility in the Workplace
  • Lunch Discussion: Ladder for LQ: What’s your Leadership Identity?

*Spotlight Session:  Becoming All You Are: Building Your Authentic Leadership in Times of Chaos

*Awards & Reception:  WISDM Professional Achievement Awards @ 2 p.m., Schools of Medicine and Dentistry. Reception at 5:00 p.m. 

Join colleagues to gain skills and insights, renew energy, and invest in your professional career!

For additional information about the WISDM Leadership Conference, visit http://www.medschool.vcu.edu/wims/wisdm/leadershipconference/ or contact Kimberly Sanford, M.D., WISDM Faculty Organization President, kimberly.sanford@vcuhealth.org or Debbie Stewart, Conference Coordinator, SOM Office of Faculty Affairs, deborah.stewart@vcuhealth.org, 828-6591.

Sponsored by: VCU School of Medicine, VCU School of Dentistry VCU Health System, McGuire Veterans Affairs Medical Center

Monday, April 30, 2018

Pathology Grand Rounds, Bryce Hatfield, MD, 'Tumor Infiltrating Lymphocytes in the Breast: Past, Present, and Future'

Noon
Sanger Hall

At the conclusion of this activity, the participant will be able to:

1.  Describe methods of quantifying stromal tumor infiltrating lymphocytes in breast biopsies and resection specimens

2. Understand the prognostic utility of tumor infiltrating lymphocytes in the breast

3. Discuss the implications of tumor infiltrating lymphocytes in immunotherapy

 

Monday, May 7, 2018

Pathology Grand Rounds, Elizabeth Martin, MD Cytopathology Fellow, Virginia Commonwealth University Health System

Noon
Sanger Hall

"Renal Medullary Carcinoma (RMC) and Renal Cell Carcinoma Unclassified with Medullary Phenotype (RCCU-MP): Findings in 15 Cytologic Samples"

At the conclusion of this activity, the participant will be able to:

  1. To review the histologic, cytologic and molecular features of renal medullary carcinoma (RMC).
  2. To contrast this to the recently described renal cell carcinoma unclassified with medullary phenotype (RCCU-MP), with particular emphasis on the cytologic findings.
  3. To briefly review the differential diagnosis and specific diagnostic challenges of work-up of a RMC or RCCU-MP.

Monday, May 14, 2018

Pathology Grand Rounds, Michael Oellerich, MD, Hon MD, George-August-University, University Medical Center Goettingen

Noon
Sanger Hall

Circulating Cell-Free DNA as a Diagnostic Tool in Cancer and Transplantation

At the conclusion of this activity, the participant will be able to:

1. To understand the rationale for using graft-derived cell-free DNA analysis in organ transplantation, including some recent evidence for its clinical utility
2. To appreciate the methodology used and the applications of circulating cell-free plasma DNA analysis in cancer
3. To be able to explain the diagnostic and prognostic value of chromosomal instability as assessed in tumor-derived cell-free DNA

Tuesday, May 15, 2018

Pathology Grand Rounds, Ruth A. Keri, Ph.D., Mechanism-based Therapeutic Discovery in Breast Cancer

Noon
Sanger Hall

At the conclusion of this activity, the participant will be able to:

1. Attendees will be able to discriminate between subtypes of breast cancer and the importance of these subtypes in treating disease.
2. Attendees will be able to explain the limitations of mTOR inhibition for cancer therapy and approaches used to overcome those limitations.
3. Attendees will be able to describe the mechanisms of action of the epigenetic BET inhibitors in triple negative breast cancer.